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CalciumDuchennemuscular dystrophy is a fatal X-linked genetic disease, causedbymutations in the dystrophin gene,which
cause functional loss of this protein. This pathology is associated with an increased production of reactive oxygen
(ROS) and nitrogen species. The aim of this work was to study the alterations in NF-κB activation and interleukin-
6 (IL-6) expression induced by membrane depolarization in dystrophicmdxmyotubes. Membrane depolarization
elicited by electrical stimulation increased p65 phosphorylation, NF-κB transcriptional activity and NF-κB-depen-
dent IL-6 expression in wtmyotubes, whereas in mdx myotubes it had the opposite effect. We have previously
shown that depolarization-induced intracellular Ca2+ increases and ROS production are necessary for NF-κB activa-
tion and stimulation of gene expression in wtmyotubes. Dystrophic myotubes showed a reduced amplitude and
area under the curve of the Ca2+ transient elicited by electrical stimulation. On the other hand, electrical stimuli in-
duced higher ROS production inmdx thanwtmyotubes, which were blocked by NOX2 inhibitors. Moreover, mRNA
expression and protein levels of the NADPH oxidase subunits: p47phox and gp91phox were increased in mdx
myotubes. Looking at ROS-dependence of NF-κB activation we found that in wtmyotubes external administration
of 50 μM H2O2 increased NF-κB activity; after administration of 100 and 200 μM H2O2 there was no effect. Inmdx
myotubes there was a dose-dependent reduction in NF-κB activity in response to external administration of H2O2,
with a signiﬁcant effect of 100 μMand 200 μM, suggesting that ROS levels are critical for NF-κB activity. Prior block-
agewith NOX2 inhibitors blunted the effects of electrical stimuli in both NF-κB activation and IL-6 expression. Final-
ly, to ascertain whether stimulation of NF-κB and IL-6 gene expression by the inﬂammatory pathway is also
impaired inmdxmyotubes,we studied the effect of lipopolysaccharide onbothNF-κB activation and IL-6 expression.
Exposure to lipopolysaccharide induced a dramatic increase in both NF-κB activation and IL-6 expression in bothwt
andmdxmyotubes, suggesting that the altered IL-6 gene expression after electrical stimulation inmdxmuscle cells is
due to dysregulation of Ca2+ release and ROS production, both of which impinge on NF-κB signaling. IL-6 is a key
metabolic modulator that is released by the skeletal muscle to coordinate a multi-systemic response (liver, muscle,
and adipocytes) during physical exercise; the alteration of this response in dystrophicmusclesmay contribute to an
abnormal response to contraction and exercise.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Duchenne muscular dystrophy (DMD) is a lethal X-linked human
genetic muscular disorder caused by mutations in the dystrophin geneolecular Biosciences, School of
89 Veterinary Medicine Drive,
ncias Biomédicas, Facultad de
Chile.
irano@gmail.comthat lead to the absence of dystrophin protein [1]. DMD is a severe
and progressive muscle wasting disease leading to wheelchair
dependence and premature death [2]. DMD patients have an abnormal
response to exercise compared to control subjects [3,4] and it has been
shown that running exercise induces rapid muscle damage [5], cell
death and worsening of the muscle pathology [4]. However, beneﬁcial
effects of exercise through utrophin upregulation in dystrophic patients
have been reported as well [6].
A hallmark feature of DMD pathology is the excessive inﬂammation
observed in the skeletal muscles due to immune cell inﬁltrates and
an increase in inﬂammatory mediators [7,8]. Interleukin-6 (IL-6) is a
ubiquitously expressed cytokine with either pro- or anti-inﬂammatory
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centration [9]. In DMD patients, as well as in the mdx mouse
(a DMD model) elevated IL-6 levels have been found both in
plasma and muscle [10,11]. Recently, we reported that there were no
differences in IL-6 gene expression between wt and mdx myotubes
[12], suggesting that it is the immune cell inﬁltrates rather than the
skeletal muscles themselves that produce the elevated levels of this
cytokine.
In normal patients and animals, IL-6 plasma levels are increased by
exercise and it appears that contracting muscles are the source of this
increase [13]. IL-6 plays a central role in muscle communication with
several tissues such as the liver, adipose cells, and other muscles to
increase energy supply during exercise,making it an essentialmetabolic
regulator [13,14]. Several intracellular signaling pathways have been
related to IL-6 expression in the skeletal muscle including NF-κB
activation, and reactive oxygen species (ROS) production [14,15]. In
skeletal muscle cells, membrane depolarization activates NF-κB by a
mechanism involving Ca2+ release from the sarcoplasmic reticulum
(SR) and ROS production [16]. ROS and reactive nitrogen species
(RNS) have long been implicated in cellular damage andwe have previ-
ously reported an increase in iNOS expression and nitric oxide (NO)
production in mdxmyotubes [12]. ROS and RNS have also emerged as
important physiological signaling molecules that modify receptor stim-
ulation, enzymatic activity and gene expression in skeletal muscle cells
[17]. In normal skeletal muscle NADPH oxidase (NOX) is a major source
of ROSboth at rest andduring contraction [18–20]. NOX2 is foundmain-
ly in transverse tubules [21] and consists in regulatory cytosolic units
(p47phox, p67phox, and p40phox), a GTPase protein (rac 1), and the cata-
lytic membrane-bound subunits: gp91phox and p22phox. Several studies
have shown that NOX2 activity is altered inmdxmuscle and could play
an important role in dystrophic pathophysiology [22,23].
Until now, there have been no studies addressing the molecular
mechanism involved in NF-κB activation and IL-6 production elicited
by membrane depolarization in dystrophic skeletal muscle cells.
The aim of this work was to study the alterations in both NF-κB
activation and IL-6 gene expression induced by ES between wt and
mdxmyotubes.2. Material and methods
2.1. Cell culture
Primary myotubes from wild type (C57BL/6) and mdx
(C57BL/10ScSn-DmdbmdxN/J) mice were isolated according to the
method of Rando and Blau [24]. The myoblasts were grown and
differentiated as described previously [25]. For experiments myoblasts
were seeded in matrigel-coated dishes or coverslips. When cells
reached approximately 70% conﬂuence, growth medium was replaced
with differentiation medium (DMEM low glucose, 4% heat inactivated
horse serum and 1× Pen–Strep–Glutamine solution) to induce
myoblast differentiation. The medium was changed every two days
and cells were used for experimental determinations at days 3–4 of
differentiation.2.2. Swimming exercise protocol
A 1-liter beaker ﬁlled with water at room temperature was used as
swimming pool. Brieﬂy, wt and mdx mice were gently placed in the
water to perform 1 h of swimming (without any weight on the tail).
Later, mice were removed immediately from the swimming pool,
dried gently with paper towels and returned to their cages. After 2 h
the animals were euthanized, their diaphragm muscles were dissected
and RNA was extracted using the TRIzol reagent according to the
manufacturer's instructions.2.3. Electric stimulation protocol
Myotubeswere stimulatedwith a stimulation device, that consists of
six rows of platinum wires, intercalated 0.5 cm apart, with alternate
polarity across a circular Teﬂon holder that ﬁts in the dish. This was
connected to a Grass S48 pulse generator, as described previously [26].
The protocol for electrical stimulation (ES) used was a single train of
250 square wave pulses of 0.5 ms duration at a frequency of 20 Hz
(12.5 s total). This protocol was previously shown to be effective in
inducing both Ca2+ signaling and gene expression in skeletal muscle
cells [26]. For some experiments, high potassium solution (85 NaCl, 60
KCl, 2.5 CaCl2, 1 MgCl2, 5.6 glucose, 10 HEPES–Tris, pH 7.4) was used
to study the magnitude of NF-κB activation. Depolarization proceeded
during 1 min in the high potassium solution, returning to normal
physiological solution (140 NaCl, 5 KCl, 2.5 CaCl2, 1 MgCl2, 5.6 glucose,
10 HEPES–Tris, pH 7.4). Protein samples were obtained 30 or 60 min
after high potassium depolarization protocol.
2.4. Western blot
Total protein lysateswere prepared fromdifferentiatedmyotubes by
homogenizing them in a lysis buffer containing 20 mM Tris–HCl
(pH 7,5), 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 20 mM NaF,
1 mM Na2P2O7, 10% glycerol, 150 mM NaCl, 10 mM Na3VO4, 1 mM
PMSF and protease inhibitors (Complete™, Roche Applied Science).
Proteins were separated using SDS-PAGE and transferred to PVDF
membranes. The following primary antibodies and their dilutions
were used: gp91phox (1:1000; Santa Cruz Biotechnology); p-p65
(Ser536; 1:2000; Cell Signaling), p65 (total; 1:2000; Cell Signaling),
IκBα (1:1000; Cell Signaling), β-tubulin (1:1000, Sigma Aldrich) and
GAPDH (1:10,000; Cell Signaling). The protein bands in the blots were
visualized using either HRP secondary antibodies and autoradiography
ﬁlms or quantiﬁed with Odyssey Imaging System (Li-COR Biosciences).
2.5. NF-κB luciferase reporter activity determinations
Both wt and mdx myoblasts were transduced with a lentivirus
containing 5 tandem NF-κB binding site repeats cloned upstream of a
luciferase reporter gene and populations that stably expressed the
transgene were selected using G418, as described previously [12].
Myotubes were stimulated in differentiation media. Luciferase activity
was determined using the luciferase reporter assay system (Promega)
according to the manufacturer's instructions. Light detection was
carried out in a Berthold F12 luminometer. Results were normalized
with total protein and the ratio “luciferase mg−1” was shown.
2.6. ELISA
Culture media (DMEM with 5% heat inactivated horse serum and
antibiotics) were changed one day before the experiment to allow
basal IL-6 release stabilization. The ES protocol was applied as described
above and after 2 h media samples (1 mL) were collected from both an
ES-stimulated dish and a control dish (no media change before the
experiment). Supernatants were spun at 10,000 ×g for 1min to remove
any cellular debris and kept on ice. ELISA was carried out immediately
using a Mouse IL-6 High Sensitivity ELISA Kit (Affymetrix eBioscience
#BMS603HS) according to the manufacturer's instructions. Total
proteins were extracted with lysis buffer and the protein concentration
was assessed with the BCA method. IL-6 levels (pg/mL) were normal-
ized to the total protein (mg).
2.7. Ca2+ transients
Differentiated myotubes were loaded with 5 μM with Fluo3-AM at
37 °C, 30 min in normal physiological solution. Image series during
stimulation experiments were obtained with an inverted microscope
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equipped with a CCD cooled camera (QImaging, Retiga 2000R) every
0.7 s at room temperature (RT). A ﬁlter Wheel (Lambda 10-2, Sutter
Instruments) was used to ﬁlter 484­nm wavelength. The experiments
were performed in Krebs–Ringer's solution (in mM: 140 NaCl, 5 KCl, 1
MgCl2, 1 CaCl2, 5.5 glucose, 10 HEPES, pH 7.4). Fluorescence images
were analyzed with ImageJ software (NIH, Bethesda) and the average
cell ﬂuorescence, F, was calculated from selected regions of interest
(ROI). Fluorescence data (F) normalized with respect to basal ﬂuores-
cence (F0) were expressed as [F− F0] / F0 (ΔF/F0).
2.8. ROS production
Myotubes were loaded with 5 μMCM-H2DCFA for 15min at 37 °C in
imaging solution. The cells on coverslips were washed with Ringer
solution and placed on the stage of confocal microscope (Carl Zeiss
Pascal 5, LSM) at RT. The experiments were performed in Krebs–
Ringer's solution (in mM: 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 5.5 glucose,
10 HEPES, pH 7.4). CM-H2DCFA ﬂuorescence was detected using excita-
tion at 488 nm and emission at 510–540 nm. In all measurements, a
control with laser excitation only was performed. The laser illumination
was kept at a minimum to prevent light activation of the dye. Fluores-
cence images were analyzed with ImageJ software (NIH, Bethesda)
and the average cell ﬂuorescence, F, was calculated from selected
regions of interest (ROI). Fluorescence data (F) normalized with
respect to basal ﬂuorescence (F0) of wt myotubes were expressed as
[F− F0] / F0 (ΔF/F0).
2.9. Real time PCR
Total RNA from myotube cultures was isolated with TRIzol reagent
(Invitrogen) and cDNA was prepared using SuperScript II (Invitrogen)
according to themanufacturer's protocol. Real­time PCRwas performed
using a Stratagene Mx3000P as follows: Primers were used at 400 nM
ﬁnal concentrations and 2 μL of cDNA reaction together with the
appropriate primers was added to 10 μL Brilliant III UltraFast SYBR
green QPCR Master mix (Agilent Technologies) to a total volume of
20 μL. No-template control (NTC) reactions were also prepared for
each gene. The cycling parameters for all genes were the following:
95 °C for 3 min, then 50 cycles of 95 °C for 20 s, and 60 °C for 20 s.
Expression values were normalized to GAPDH and are reported in
units of 2−ΔΔCt [27]. PCR products was veriﬁed by melting-curve
analysis and resolved by electrophoresis on 2% agarose gel and stained
with ethidium bromide. The p47phox, gp91phox, IL-6 and GAPDH mRNA
transcripts were quantiﬁed using oligonucleotide primers designed
based on sequences published in NCBI GenBank with the open-source
PerlPrimer software [28], using the following primers:
gp91phox 5′-TCACATCCTCTACCAAAACC-3′ and 5′-CCTTTATTTTTCCC
CATTCT-3′;
p47phox 5′-AGAACAGAGTCATCCCACAC-3′ and 5′-GCTACGTTATTCT
TGCCATC-3′;
gapdh 5′-CTCATGACCACAGTCCATGC-3′ and 5′-TTCAGCTCTGGGA
TGACCTT-3′;
IL-6 5′-CCAATTTCCAATGCTCTCCT 3′ and 5′-ACCACAGTGAGGAATG
TCCA-3′.
2.10. Statistics
All values are expressed as mean ± SEM from at least 3 different
independent determinations. Data were normalized to wt values at
control conditions. Statistical analysis was performed using either
unpaired two-tailed t test or ANOVA-with Dunnett's correction to
determine signiﬁcance (P b 0.05).3. Results
3.1. Depolarization-induced NF-κB activation is impaired in mdx
myotubes
Membrane depolarization by either ES or high extracellular
potassium has been shown to activate NF-κB in wt skeletal muscle
cells [16]. In order to study any alterations in NF-κB activation we
studied the levels of p-p65 (Ser536), p65 and IκBα by western blot as
well as NF-κB transcriptional activity. Inwtmyotubes electrical stimula-
tion (250 pulses of 0.5 ms of duration at 20 Hz frequency) increased p-
p65 levels at 30 min (P b 0.05), which returned to nonsigniﬁcant levels
above baseline at 60 min (Fig. 1A and B) but no signiﬁcant changes in
total p65 and IκBα levels were observed at any time point (Fig. 1C and
D). Similar results were observed in wt myotubes after potassium
depolarization protocol at 30 min, however the increase in p-p65 levels
did not reach statistical signiﬁcance, probably due to the differences in
the duration of the depolarization protocol and its effects in the time
course of NF-κB activation (Fig. 1). Inmdxmyotubes, electrical stimuli
did not modify p-p65, p65 or IκBα levels (Fig. 1A–D). NF-κB transcrip-
tional activity, assessed by a luciferase reporter, increased by 2-fold at
12 h post-ES in wtmyotubes (P b 0.05) (Fig. 1E), and had the opposite
effects on NF-κB transcriptional activity, reducing it by 2-fold after
stimulation at 12 h (P b 0.05) in dystrophic myotubes (Fig. 1E). NF-κB
transcriptional activity was elevated in mdx myotubes at resting
conditions, and this was correlated with reduced IκBα levels, reduced
p-p65 (Fig. 1B, D and E).3.2. Depolarization-induced IL-6 expression is altered in mdx myotubes
Membrane depolarization increases IL-6 gene expression in human
and rat myotubes [14,29] and this increased expression requires
activation of NF-κB [14]. Here we studied the changes in IL-6 mRNA
levels induced by ES by real time PCR. In wtmyotubes ES signiﬁcantly
increased IL-6 mRNA levels by 2.9 and 2.5-fold at 2 and 3 h post-
stimuli, respectively (P b 0.001 and P b 0.01 compared to basal value)
(Fig. 2A). On the contrary, ES reduced IL-6 mRNA levels in mdx
myotubes, reaching a 78% reduction at 3 h post-stimuli (P b 0.01)
(Fig. 2A).3.3. NF-κB is involved in depolarization-induced IL-6 expression
Some studies have shown that IL-6 gene expression can be
controlled by NFAT and AP-1 rather than NF-κB [13]. To determine
the effects of NF-κB inhibition on IL-6 gene expression, we applied
50 μM SN50, a cell permeable NF-κB inhibitory peptide [30], 30 min
before ES and kept it on the cells during the entire experiment. IL-6
was signiﬁcantly increased 2 h after ES in wt myotubes, compared
to un-stimulated myotubes (P b 0.05) (Fig. 2B) and SN50 treatment
prevented the increase in IL-6 mRNA. In addition, SN50 treatment
prevented the reduction in IL-6 mRNA levels after membrane depo-
larization in mdxmyotubes (Fig. 2B). Secreted IL-6 levels were mea-
sured in culture supernatants from wt and mdx myotubes using a
high sensitivity ELISA kit. ES signiﬁcantly increased the IL-6 secretion
from 8.5 ± 1.4 to 14.1 ± 1.1 pg/mg protein (P b 0.05) inwtmyotubes
(Fig. 2C). Surprisingly, we found that the basal IL-6 release was
augmented in mdx myotubes to 95.9 ± 4.8 pg/mL despite the fact
that basal IL-6 mRNA was not different from wtmyotubes. However,
after ES there was no signiﬁcant change in mdxmyotubes (P N 0.05),
supporting our hypothesis that dystrophic skeletal muscle cells fail
to increase the expression and release of IL-6 after membrane depo-
larization. This suggests that there is an altered secretion route for
IL-6 that is normally pre-pooled inside the cell and released during
exercise [31].
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Fig. 1. NF-κB activation after membrane depolarization is impaired inmdxmyotubes. Cells were stimulated at 250 pulses of 0.5 ms of duration at 20 Hz or with 60 mM K+ solution for
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exercise in mice
To examine whether the alteration of IL-6 expression was relevant
to exercised skeletal muscles of dystrophic mice we used a swimming
protocol to assess these phenomena in vivo. Mice were allowed to
swim for 1 h and then, 2 h post-exercise, they were euthanized,
mRNA was extracted and the IL-6 expression was assessed by real
time PCR. Aswe expected, swimming exercise increased IL-6 expression
by 2.9-fold (P b 0.05) in diaphragm muscles from wt mice (Fig. 2D).
Basal IL-6 expression was elevated in dystrophic diaphragms by 3.7-
fold compared towt, and swimming exercise did not modify its expres-
sion level (P N 0.05).
3.5. Ca2+ transients after membrane depolarization
We have previously demonstrated that depolarization-induced NF-
κB activation depends on changes in both intracellular Ca2+ concentra-
tion and ROS production [16,32]. We studied the Ca2+ transient elicited
by ES using Fluo3-AM and epiﬂuorescence microscopy. Dystrophicmdx
myotubes showed a reduced area under the curve of the Ca2+ transient
elicited by ES (≈50%, P b 0.001 see Fig. 3).
3.6. ROS production induced by depolarization is higher in mdx myotubes
To study the ROS production induced by ES, myotubes were loaded
with CM-H2DCFDA (5 μM), a nonspeciﬁc redox probe that emitsﬂuorescence when oxidized. The ﬂuorescence changes over time were
determined by confocal microscopy. Basal ﬂorescence was in-
creased in mdx myotubes (Fig. S1). Membrane depolarization by
ES increased ROS production in both wt and mdx myotubes
(Fig. 4A and B) but the rate of ROS production was signiﬁcantly
higher in mdx myotubes compared with wt myotubes (0.49 vs
0.32 afu/s, P b 0.05) (Fig. 4C).3.7. Catalytic and regulatory subunits of NADPH oxidase are over-expressed
in mdx myotubes
NOX2 is the main ROS source in skeletal muscle cells [33], previous
studies have shown an overexpression in mdx muscles [22,23]. In
order to establish the contribution of NOX2 to depolarization-induced
ROS production, we applied one of two NOX2 inhibitors (gp91-dstat
peptide (1 μM) or apocynin (5 μM)) prior to and during ES. Both
gp91-dstat and apocynin blunted the ROS production after ES
(P b 0.001), but the inhibitory effect of NOX2 inhibitors was higher in
mdxmyotubes than in wt. We then measured the mRNA expression of
two key subunits of the NADPH oxidase enzyme complex; regulatory
subunit p47phox and catalytic subunit gp91phox, and found that both
the p47phox and gp91phox mRNA levels were increased by 9-fold
(P b 0.01) and 2-fold (P b 0.05), respectively in mdx compared to wt
myotubes under resting conditions (Fig. 4E). To conﬁrm this we quanti-
tated the gp91phox catalytic subunit protein levels by western blot. In
mdx myotubes, gp91phox expression was 8.5-fold higher compared
with wtmyotubes (P b 0.05) (Fig. 4F and G).
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ROS have been reported to both activate and to repress NF-κB signal-
ing depending on the intracellular pathway activated and the cell type
[34]. To determine whether ROS play a role in NF-κB activity in wt and
mdxmyotubes,we evaluated their response to exogenousH2O2.NF-κB lu-
ciferase activity was then assessed 12 h after ROS stimulation at different
doses of H2O2. Inwtmyotubes 50 μMH2O2 signiﬁcantly increased NF-κB
activity (P b 0.05) but higher doses did not show any signiﬁcant effect
(Fig. 5A). In mdxmyotubes, 50 μM H2O2 did not induce any changes in
NF-κB activity, whereas at 100 and 200 μM H2O2 there was a signiﬁcant
reduction in NF-κB activity (P b 0.05, and P b 0.01, respectively) (Fig. 5A).
3.9. NOX2 inhibition reduces the effects of ES on NF-κB activity
To establish a correlation between the NOX2-dependent ROS produc-
tion and NF-κB activation, cells were treated with apocynin (5 μM) for
30 min before and during ES. Apocynin treatment reduced basal NF-κB
activity by ~51% in mdxmyotubes, without any signiﬁcant effect in wt
myotubes (Fig. 5B). In addition, apocynin blunted the NF-κB activation
after membrane depolarization in wt myotubes (P b 0.001), while in
mdxmyotubes, apocynin treatment reduced the inhibitory effects of ES
on NF-κB activity (P b 0.05) (Fig. 5B).
3.10. NOX2 inhibition reduces depolarization effects on IL-6 gene expression
To establish a correlation between NOX2-dependent ROS produc-
tion and IL-6 gene expression, we treated myotubes either with gp91-dstat (1 μM) or the scramble version of gp91-dstat for 20 min before
and during ES. In wt myotubes, gp91-dstat treatment blocked
depolarization-induced IL-6 mRNA increases (Fig. 5C) while the scram-
ble version of gp91-dstat had no effect. In mdx myotubes gp91-dstat
treatment prevented the previously observed decreases in IL-6 mRNA
induced by ES (Fig. 5C) and the scrambled version of gp91-dstat caused
no signiﬁcant change in IL-6 mRNA compared to control.
3.11. BAPTA-AM reduces IL-6 expression after ES in wtwithout any effect in
mdx myotubes
To study the relationship between intracellular Ca2+ and IL-6 gene
expression induced by ES, we pre-incubated the myotubes with
BAPTA-AM (30 μM) 30 min after ES. In wt myotubes BAPTA-AM
reduced depolarization-induced IL-6 mRNA increases (Fig. 5D). In
dystrophic muscle cells BAPTA-AM had no effect in IL-6 mRNA levels
either at rest or in electrically stimulated conditions.
3.12. LPS increases NF-κB activity and IL-6 mRNA levels
Dystrophic mice have been shown to have high levels of serum IL-6
and increased skeletalmuscle expression of IL-6 [10,11]. To evaluate the
role of the inﬂammatory pathway as a mechanism for this increase we
studied the effect of lipopolysaccharide (LPS, 1 μg/mL) on both NF-κB
activity and IL-6 mRNA levels in dystrophic myotubes. LPS dramatically
increased NF-κB transcriptional activity assessed by a luciferase report-
er, at 12 h in both wt andmdxmyotubes (P b 0.001), but the effect was
larger in mdxmyotubes than in wt (Fig. S2). Furthermore, IL-6 expres-
sion was substantially increased 2 h after stimulation in both wt and
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Fig. 5. NF-κB dysregulation after membrane depolarization inmdxmyotubes is mediated
by excessive ROS production. A. NF-κB activity induced by H2O2 inwt andmdxmyotubes.
Cells were stimulatedwith different concentrations of exogenous H2O2. Luciferase activity
was determined after 12 h (n=3). B. NOX2 inhibition (apocynin) blunted depolarization-
induced changes in NF-κB activity in bothwt andmdxmyotubes (n = 3). C. NOX2 inhibi-
tion blocked depolarization-induced changes in IL-6 expression in both wt and mdx
myotubes (n = 3). D. BAPTA-AM (30 μM) blocked depolarization-induced changes
in IL-6 expression in both wtmyotubes. * = P b 0.05, ** = P b 0.01, and *** = P b 0.001
(indicated or versus basal wt value), and ns, no signiﬁcant difference.
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data suggest that despite the fact that NF-κB activation and IL-6 expres-
sion are impaired after ES in dystrophic myotubes, their ability to re-
spond to the inﬂammatory pathway is intact.4. Discussion
IL-6 is an importantmyokine released during exercise by the skeletal
muscles, playing an important role in muscle metabolism and regener-
ation induced by exercise. DMD pathology is characterized by a persis-
tent inﬂammatory response in the skeletal muscles due to chronic
damage. There is a basal increment of IL-6 levels in plasma and muscle
lysates fromDMDpatients; however the contribution of skeletalmuscle
ﬁbers to this pool after exercise is unknown. The aim of this research
was to study the molecular mechanism involved in IL-6 expression
evoked by ES in dystrophic muscle cells. Our main results are that
1) depolarization-induced IL-6 expression is controlled by NOX2/NF-
κB pathway in normal skeletal muscle. 2) Dystrophic skeletal muscle
cells fail to increase IL-6 after depolarization and exercise. 3) Both
altered ROS production and NF-κB activity appear to be involved in
the lack of IL-6 response to exercise in mdxmyotubes.
NADPH oxidase complex is expressed in normal skeletal muscle and
represents the main ROS source during resting and contracting
conditions [18–20]. Here, we showed that ROS production after electri-
cal stimuliwas higher inmdxmuscle cells and can be effectively blocked
by NOX2 inhibitors (Fig. 3C). The fact that the effect of NOX2 inhibitors
appears to be higher in mdx cells suggests that the proportion of ROS
produced by NOX2 is also higher in these cells. Our results are in
agreement with previous ﬁndings that ROS production induced bymuscle stretching is higher in mdx ﬁbers compared to wt ﬁbers [23,
35]. These data suggest that increments of ROS during muscle activity
may contribute to oxidative stress and signaling dysregulation observed
in DMD pathology [36]. Moreover, gene expression of key subunits for
NADPH oxidase activity, p47phox and gp91phox were upregulated in
mdx myotubes (Fig. 4D and E). These data were supported by a 9-fold
increase in protein expression for the catalytic subunit gp91phox in
mdx myotubes at resting conditions (Fig. 4F and G). Previous studies
showed an increased expression of NADPH oxidase subunits in dystro-
phicmdx ﬂexor digitorumbrevis [23], tibialis anterior [37] and diaphragm
[38], where a participation of the immune system has been suggested
[23]. In this study, we showed in an immune cell-free system that
dystrophin deﬁciency leads to an increased NADPH oxidase expression.
NF-κB family plays an essential role in normal response to cellular
stress in the skeletal muscle including redox signaling [39]. We
previously showed that basal NF-κB activity is increased inmdxmus-
cle cells as a result of an elevated resting Ca2+ concentration [12].
Here, we conﬁrmed these ﬁndings and we demonstrated that NF-
κB signaling is upregulated under resting conditions in mdx
myotubes through IκBα degradation (Fig. 1D). The increased resting
intracellular calcium concentration observed in dystrophic
myotubes [12,38] may involve calpain activation and the subsequent
IκBα degradation [40]. On the other hand, a decreased basal p65
phosphorylation at Ser536 was observed in mdx myotubes
(Fig. 1B), these results suggest that basal NF-κB activity in mdx
myotubes in the absence of immune mediators [41] does not require
phosphorylation at Ser536.
In human skeletal muscles, NF-κB has been shown to be activated
after resistance exercise [42], cycling [43], eccentric muscle contraction
[44], or ES [16,45]. In this work, we showed that membrane depolariza-
tion increased NF-κB activity in normal cells (Fig. 1B), as we previously
reported in rat myotubes [16], but this physiological response is
not observed in dystrophic muscle cells. In wtmyotubes an increase in
p-p65was observed aftermembrane depolarization thatwas correlated
with an increase in NF-κB transcriptional activity measured by NF-κB
driven luciferase reporters (Fig. 1E).
Our laboratory has reported that depolarization-induced NF-κB
activation is partially blocked by the antioxidant N-acetyl cysteine
(NAC) [16]. In the present study, apocynin treatment prevented
depolarization-induced NF-κB activation in wt myotubes (Fig. 5B),
showing the importance of ROS production suggested in previous
studies [23]. In contrast, in mdx cells the reduction of NF-κB activation
after ES was blocked by apocynin treatment, showing that physiological
NOX2-dependent ROS production is necessary to positively modulate
NF-κB signaling (Fig. 5B). We hypothesize that the elevated ROS levels
at resting conditions and the increase produced by membrane depolar-
ization impair the NF-κB function in dystrophic cells. This hypothesis is
supported by the fact that lower doses of H2O2 increased NF-κB activity
whereas higher doses have no effect inwtmyotubes but that in dystro-
phic muscle cells, low doses had no effect but higher concentrations of
H2O2 reduced NF-κB transcriptional activity (Fig. 5A). ROS can both
activate or repress NF-κB signaling depending on the cell type, levels
and localization (reviewed in [34]). ROS stimulate NF-κB pathway in
the cytosol, whereas inhibit its activity in the nucleus. Elevated ROS
may inhibit NF-κB binding ability due to a cysteine oxidation in the
p50 subunit. Moreover, oxidation of IKK on Cys-179 inactivates NF-κB
signaling. There are many examples in the literature for NF-κB
inhibition by ROS [34]. Considering the elevated levels of NO due to
iNOS [12] in mdx muscles and the increase of ROS after membrane
depolarization it is possible that these redox modiﬁcations may impair
the NF-κB signaling pathway [48,49].
After depolarization with our stimulation protocol (one train, 250
pulses at 20 Hz), we found that IκBα levels remain similar to untreated
cells (Fig. 1A). There is some evidence showing that p65 phosphoryla-
tion at Ser536 targets to an IκBα independent pathway for NF-κB
activation [46]. A reduced binding of NF-κB to IκB due to increased
Fig. 6. Proposedmodel for NF-κB and IL-6 dysregulation in dystrophicmyotubes. Inwt skeletal muscle cells (left panel)membrane depolarization increase NOX2-dependent ROS produc-
tion and triggers Ca2+ release from intracellular reservoirs. Both Ca2+ and ROS levels are necessary to increase NF-κB transcriptional activity, and subsequently IL-6 gene expression. In
mdx skeletal muscle cells (right panel), NOX2 overexpression increase ROS levels after membrane depolarization that negatively affects NF-κB transcriptional activity and IL-6 mRNA
levels. In addition, Ca2+ signals elicited bymembrane depolarization that are necessary for NF-κB activation are signiﬁcantly reduced. IL-6 is a key regulator ofmetabolism and participates
in the coordination of several organs during exercise. The impairment in IL-6 production might exacerbate muscle dysfunction in patients with DMD.
1417C. Henríquez-Olguín et al. / Biochimica et Biophysica Acta 1852 (2015) 1410–1419phosphorylation at ser536 of p65 subunit of NF-κB has been reported in
response to H2O2 [50,51]. Moreover, it has been reported that NF-κB
activation without IκBα degradation, due to IκBα association to PI3K
leading NF-κB to migrate to the nucleus [47]. Moreover, our lab previ-
ously demonstrated that IκBα degradation depends on the frequency
and duration of the stimuli [16].
ROShave been linkedwith IL-6 expression [15] and there is evidence
showing that antioxidant administration might reduce IL-6 release by
the skeletal muscle [52]. However, the source of ROS involved in this
process is unclear. Our results showed that in wt cells, inhibition of
NOX2 by the mimetic peptide gp91-dstat reduces IL-6 expression. In
contrast, in mdx cell inhibition of NOX2 prevents repression of IL-6
expression after ES. Collectively, our data suggest that an excessive
NOX2-mediated ROS production inhibits the NF-κB-dependent
transcription of IL-6 gene, ablating its expression after membrane
depolarization and impairing its secretion.
Our results demonstrate that IL-6 secretion is elevated in resting
conditions in mdx myotubes, but mRNA levels are similar to those
observed in wt myotubes. This can be achieved at different levels of
regulation (e.g. post-transcriptional, translational, or secretion route).
These basal differences might be due to an altered secretion of pre-
formed IL-6 pool; although this was not the aim of this work, this is an
interesting ﬁnding because it may reﬂect and altered IL-6 secretion
similar to the one observed in plasma and muscle lysates in DMD [3,
4]. Our data suggest that dystrophic skeletal muscle cells fail to express
and secrete IL-6 in response tomembrane depolarization or exercise. IL-
6 is an endocrine, paracrine, and autocrine-signaling molecule. It is
essential for a normal response to exercise, acting as an important
metabolic regulator [13,29]. Thus, its alteration in dystrophic muscle
cells can affect the normal response to contractile activity and impair
muscle function [53,54]. Moreover, studies in rodents have shown that
IL-6 contributes to muscle regeneration or hypertrophy after injury
which may involve a similar stimulatory effect on satellite cell prolifer-
ation [55] and up-regulation of utrophin [56]. It seems that IL-6 has a
dual effect in muscle physiology depending on its temporal releaseand concentration [31]. After membrane damage, muscle elevation of
IL-6 appears to be due to leukocyte activation (mast cells, neutrophils,
monocytes and macrophages) and it is necessary for muscle repair
[57]. IL-6 null mice showed an abnormal muscle repair, pointing to
the importance of this cytokine in the regeneration process [58].
Moreover, blockade of IL-6 in mdxmice is deleterious supporting this
hypothesis [59]. On the other hand, during exercise IL-6 is a key
energetic regulator that coordinates multiple organs to fulﬁll the
energetic muscle requirements [13]. IL-6 release is transient, peaking
at the end of exercise and then returning to basal levels [31]. The
absence of an IL-6 increase after exercise due to altered NF-κB signaling
in dystrophic muscles could induce metabolic dysfunctions and lack of
adaptation in the skeletal muscles that undergo physical activity.
Contrary to ES response, stimulation with LPS induces activation of
NF-κB and IL-6 expression in both skeletal myotubes (Fig. S1). These
data suggest that despite the fact that NF-κB activation and IL-6 expres-
sion are impaired after ES in dystrophic myotubes, they are able to re-
spond to the inﬂammatory stimuli.
The NF-κBmolecular mechanisms that explain the differences in the
response to LPS should be explored in future studies.
In summary, we have found that the IL-6 gene expression triggered
by membrane depolarization is impaired in mdx myotubes, due to an
increased NOX2-dependent ROS production and reduced NF-κB
activation after depolarization (Fig. 6). This altered pathway may well
be on the basis of reduced muscle regeneration and increased cell
death associated with the absence of dystrophin, andmay be generaliz-
able to other muscle diseases as well.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.03.012.Transparency document
The Transparency document associated with this article can be
found, in the online version.
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